DICP OpenIR
学科主题物理化学
Inhibitory Effects of Dibenzocyclooctadiene lignans from Fructus schisandrae on CYP2C8-mediated Paclitaxel Metabolism in Human Liver Microsomes
Zhang YY(张延延); Yang L(杨凌)
会议名称3rd Asian Pacific Regional Meeting of the International-Society-for-the-Study-of-Xenobiotics
会议日期2009-5-10
2009-05-10
会议地点THAILAND
其他题名五味子木脂素成分对CYP2C8介导的紫杉醇代谢抑制作用
页码87/2
ISSN0360-2532
部门归属十八室
英文摘要Inhibitory Effects of Dibenzocyclooctadiene Lingans from Fructus Schisandrae on CYP2C8-Mediated Paclitaxel Metabolism in Human Liver Microsomes Yan-Yan Zhang, Ling Yang Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, 116023 China Dibenzocyclooctadiene lingans are the principle active ingredients of Fructus Schisandrae, which is extensively used as an antitussive, sedative and tonic agent in China, Korea, Japan and Russia. According to Chinese Pharmacopoeia 2005 edition, these lingans are recognized as the major constituents in this Chinese herb medicine. Recently, schisandra extract and some purified lingans have been found to enhance the efficacy of paclitaxel against multidrug resistance tumor cell lines1. In the present study, an in vitro study was undertaken to evaluate the influence of 7 major Schisandra lingans on CYP2C8, which is the primary metabolic enzyme for paclitaxel. Among all these components, gomisin G (IC50=4.3±0.7 µM) exhibited the most potent inhibitory effect on CYP2C8-dependent paclitaxel 6α-hydroxylation in noncompetitive manner, with apparent Ki value of 4.1 µM. Gomisin A (IC50= 8.7±0.8 µM, Ki=8.6 µM) and pregomisin (IC50= 9.3±0.8 µM, Ki=8.0 µM) were also found to potently inhibit CYP2C8 in noncompetitive and competitive manner, respectively. However, schizandrol A (IC50>100 µM), schizandrin A (IC50= 31.8±1.7 µM), B (IC50= 12.6±1.9 µM) and C (IC50>100 µM) were considered less likely to cause drug-drug interactions via inhibition of CYP2C8 activity. Since paclitaxel holds a complex pharmacological and toxicological profile with a narrow therapeutic window2, special attention should be taken on the alteration of paclitaxel pharmacokinetic behavior, when coadministered with the corresponding dibenzocyclooctadiene lingans or the crude extract of Fructus Schisandrae. Reference 1. Huang M, Jin J, Sun H, Liu GT. Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae. Cancer Chemother Pharmacol 2008 62(6):1015-1026. 2. Mielke S, Sparreboom A, Steinberg SM, Gelderblom H, Unger C, Behringer D, Mross K. Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer. Clin Cancer Res 2005 11(13): 4843-4850.
语种中文
WOS记录号WOS:000269483300178
引用统计
文献类型会议论文
条目标识符http://cas-ir.dicp.ac.cn/handle/321008/113562
专题中国科学院大连化学物理研究所
通讯作者Yang L(杨凌)
推荐引用方式
GB/T 7714
Zhang YY,Yang L. Inhibitory Effects of Dibenzocyclooctadiene lignans from Fructus schisandrae on CYP2C8-mediated Paclitaxel Metabolism in Human Liver Microsomes[C],2009:87/2.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[张延延]的文章
[杨凌]的文章
百度学术
百度学术中相似的文章
[张延延]的文章
[杨凌]的文章
必应学术
必应学术中相似的文章
[张延延]的文章
[杨凌]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。